bromopyruvate has been researched along with Prostatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, FH; Hu, JY; Li, LK; Wang, LM; Zhang, XJ | 1 |
| Dong, K; Han, S; Jiang, C; Shen, M; Wang, X; Xu, D; Xu, Y | 1 |
| Bartosz, G; Madeja, Z; Pichla, M; Pienkowska, N; Piwowarczyk, K; Sadowska-Bartosz, I; Sroka, J | 1 |
| de Bari, L; Vacca, RA; Valenti, D | 1 |
4 other study(ies) available for bromopyruvate and Prostatic Neoplasms
| Article | Year |
|---|---|
[Inhibitory effect of 3-bromopyruvate on the proliferation, migration and invasive ability of prostate cancer PC-3 cells].
Topics: Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Male; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; PC-3 Cells; Prostatic Neoplasms; Pyruvates | 2020 |
LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2.
Topics: Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Glycolysis; Humans; Male; Membrane Proteins; Prostatic Neoplasms; Pyruvates; RNA, Long Noncoding; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2017 |
Metastatic prostate cancer cells are highly sensitive to 3-bromopyruvic acid.
Topics: Actin Cytoskeleton; Adenosine Triphosphate; Animals; Cell Line; Cell Line, Tumor; Cell Movement; Glutathione; Humans; Male; Neoplasm Invasiveness; Prostate; Prostatic Neoplasms; Pyruvates; Rats | 2019 |
3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system.
Topics: Cell Death; Energy Metabolism; Glycolysis; Humans; Male; Mitochondria; Prostatic Neoplasms; Pyruvates | 2015 |